Cargando…

Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma

To determine whether measuring antibodies against Epstein-Barr virus (EBV) glycoprotein gH/gL in serum could improve diagnostic accuracy in nasopharyngeal carcinoma (NPC) cases, gH/gL expressed in a recombinant baculovirus system was used in an enzyme-linked immunosorbent assay (ELISA) to detect ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Rui-Chen, Du, Yong, Zeng, Qiu-Yao, Tang, Lin-Quan, Zhang, Hua, Li, Yan, Liu, Wan-Li, Zhong, Qian, Zeng, Mu-Sheng, Huang, Xiao-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941321/ https://www.ncbi.nlm.nih.gov/pubmed/27093005 http://dx.doi.org/10.18632/oncotarget.7688

Ejemplares similares

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1976)

IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
por: Ho, H. C., et al.
Publicado: (1977)

Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

The KGD Motif of Epstein-Barr Virus gH/gL Is Bifunctional, Orchestrating Infection of B Cells and Epithelial Cells
por: Chen, Jia, et al.
Publicado: (2012)

Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma
por: Yu, Xia, et al.
Publicado: (2020)

Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry
por: Wu, Yiquan, et al.
Publicado: (2017)

Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients
por: Schieber, Jennifer, et al.
Publicado: (2023)

The Murid Herpesvirus-4 gH/gL Binds to Glycosaminoglycans
por: Gillet, Laurent, et al.
Publicado: (2008)

Distribution of the CMV glycoprotein gH/gL/gO and gH/gL/pUL128/pUL130/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally
por: Paradowska, Edyta, et al.
Publicado: (2019)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA
por: Xue, Ning, et al.
Publicado: (2019)

Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein‐Barr virus capsid antigen: A mediation analysis
por: Hsu, Wan‐Lun, et al.
Publicado: (2020)

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population
por: Mao, Min-jie, et al.
Publicado: (2018)

Crystal structure of the conserved herpesvirus fusion regulator complex gH–gL
por: Chowdary, Tirumala K., et al.
Publicado: (2010)

Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex
por: Wussow, Felix, et al.
Publicado: (2014)

Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms
por: Fricke, Thomas, et al.
Publicado: (2022)

Tetrameric glycoprotein complex gH/gL/gQ1/gQ2 is a promising vaccine candidate for human herpesvirus 6B
por: Wang, Bochao, et al.
Publicado: (2020)

Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
por: Su, Hang, et al.
Publicado: (2021)

Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
por: Perez, Elizabeth M., et al.
Publicado: (2016)

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Zhu, Qian-Ying, et al.
Publicado: (2020)

The Murid Herpesvirus-4 gL Regulates an Entry-Associated Conformation Change in gH
por: Gillet, Laurent, et al.
Publicado: (2008)

Well Put Together—A Guide to Accessorizing with the Herpesvirus gH/gL Complexes
por: Gonzalez-Del Pino, Gonzalo L., et al.
Publicado: (2022)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

In Vitro Viral Evolution Identifies a Critical Residue in the Alphaherpesvirus Fusion Glycoprotein B Ectodomain That Controls gH/gL-Independent Entry
por: Vallbracht, Melina, et al.
Publicado: (2021)

Receptor Binding-Induced Conformational Changes in Herpes Simplex Virus Glycoprotein D Permit Interaction with the gH/gL Complex to Activate Fusion
por: Atanasiu, Doina, et al.
Publicado: (2023)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

Correction: The Murid Herpesvirus-4 gL Regulates an Entry-Associated Conformation Change in gH
por: Gillet, Laurent, et al.
Publicado: (2008)

Human Cytomegalovirus gH/gL Forms a Stable Complex with the Fusion Protein gB in Virions
por: Vanarsdall, Adam L., et al.
Publicado: (2016)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

Complete Protection of Mice against Lethal Murine Cytomegalovirus Challenge by Immunization with DNA Vaccines Encoding Envelope Glycoprotein Complex III Antigens gH, gL and gO
por: Wang, Huadong, et al.
Publicado: (2015)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

Plasma Macrophage Inhibitory Cytokine-1 as a Complement of Epstein-Barr Virus Related Markers in Identifying Nasopharyngeal Carcinoma
por: Xing, Shan, et al.
Publicado: (2020)

Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy
por: Zhang, Lu, et al.
Publicado: (2015)

Two Sides to Every Story: Herpes Simplex Type-1 Viral Glycoproteins gB, gD, gH/gL, gK, and Cellular Receptors Function as Key Players in Membrane Fusion
por: Jambunathan, Nithya, et al.
Publicado: (2021)

Correlation of nasopharyngeal carcinoma with rare earth elements and the Epstein-Barr virus
por: Zhang, Xiangmin, et al.
Publicado: (2018)

The Cytoplasmic Tail Domain of Epstein-Barr Virus gH Regulates Membrane Fusion Activity through Altering gH Binding to gp42 and Epithelial Cell Attachment
por: Chen, Jia, et al.
Publicado: (2016)

Expression of Epstein-Barr Viral Capsid, Complement Fixing, and Nuclear Antigens in Stationary and Exponential Phase Cultures
por: Miller, George, et al.
Publicado: (1974)

Computational repositioning of ethno medicine elucidated gB-gH-gL complex as novel anti herpes drug target
por: Basha, Syed Hussain, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_o2s9tkvfh02uj58kjivdeu49bg